Jakafi 15 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKJ3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,583
Award facts
- Contract value 100% obligated
- $12,582.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $12,582.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 15 mg. The award, issued on December 31, 2025, with an ultimate completion date of January 2, 2026, utilizes firm fixed pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V program with a $500 million ceiling value extending through December 31, 2036, positioning the company as a regional prime vendor contractor within the broader Department of Defense pharmaceutical supply chain. The vendor has demonstrated consistent performance delivering a comprehensive range of pharmaceutical products—including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables—to support military medical operations. This particular delivery order for Jakafi, an oncology treatment, reflects the company's capability to fulfill specialized pharmaceutical requirements across multiple therapeutic categories for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FKKJ3?
SPE2DR26FKKJ3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FKKJ3 worth?
The government has obligated $12,583 on SPE2DR26FKKJ3.
Is contract SPE2DR26FKKJ3 an order under another contract?
Yes. SPE2DR26FKKJ3 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKJ3 competed?
The extent of competition for SPE2DR26FKKJ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award